RETRACTED: Isolation and functional analysis of mouse UbA52 gene and its relevance to diabetic nephropathy (Retracted article. See vol. 294, pg. 10382, 2019)

被引:26
|
作者
Sun, L
Pan, XM
Wada, J
Haas, CS
Wuthrich, RP
Danesh, FR
Chugh, SS
Kanwar, YS
机构
[1] Northwestern Univ, Sch Med, Dept Pathol, Chicago, IL 60611 USA
[2] Northwestern Univ, Sch Med, Dept Med, Chicago, IL 60611 USA
[3] Okayama Univ, Dept Med, Okayama 7008558, Japan
关键词
D O I
10.1074/jbc.M204665200
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
In delineating the mechanism(s) of diabetic nephropathy various novel genes have been isolated, whereas others remain to be discovered. We identified several up-regulated genes in the kidneys of diabetic newborn mice. Among them was UbA52, a ubiquitin ribosomal fusion protein. Its mRNA expression in the kidney was proportional to blood glucose levels. By in situ hybridization and immunohistochemistry, UbA52 was exclusively localized to renal tubules, and its expression was markedly increased in diabetic mice. The up-regulated UbA52 mRNA and protein expression were also observed in Madin-Darby canine kidney cells, a tubular cell line, treated with 30 mm glucose in both cell lysates and ribosomal fractions. To explore the mechanism(s) of its increased expression, UbA52 genomic DNA was isolated. A transcription start site at -22 by from the initiation codon was identified and confirmed by primer extension analysis. The UbA52 promoter region included glucose response-related E-box sequences and stress response elements (STRE). Unlike in humans, mouse UbA52 gene had no introns in the coding or 5'-ATG-flanking regions. To identify the DNA segment with maximal promoter activity, deletion constructs were prepared using a pSEAP vector system and transfected into COS7 kidney cells. Maximal activity was confined to -198 to +68 bp, which included E-boxes and STRE motifs. A dose-dependent increase in the promoter activity was observed in cells exposed to high glucose. Mutations in the first E-box (CAGCTG --> TGGCTG) or STRE (CCCCT --> CATCT) resulted in a decrease in the SEAP activity under high glucose ambience. Given the presence of glucose-responsive motifs in the promoter region and decrease in the SEAP activity in E-box mutants in the presence of glucose, these data suggest that UbA52, a ribosomal fusion protein, may be relevant in the pathogenesis of diabetic nephropathy.
引用
收藏
页码:29953 / 29962
页数:10
相关论文
共 50 条
  • [1] RETRACTED: Pulmonary/renal interaction (Retracted article. See vol. 18, pg. 294, 2012)
    Ricci, Zaccaria
    Ronco, Claudio
    CURRENT OPINION IN CRITICAL CARE, 2010, 16 (01) : 13 - 18
  • [2] RETRACTION: Isolation and functional analysis of mouse UbA52 gene and its relevance to diabetic nephropathy (Retraction of Vol 277, Pg 29953, 2002)
    Sun, Lin
    Pan, Xiaomin
    Wada, Jun
    Haas, Christian S.
    Wuthrich, Rudolf P.
    Danesh, Farhad R.
    Chugh, Sumant S.
    Kanwar, Yashpal S.
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2019, 294 (26) : 10382 - 10382
  • [3] RETRACTED: A Highlight of Recent Advance in Immunology (Retracted article. See vol. 39, pg. 294, 2012)
    Zheng De-Xian
    PROGRESS IN BIOCHEMISTRY AND BIOPHYSICS, 2011, 38 (12) : 1111 - 1112
  • [4] RETRACTED: Management of invasive melanoma (Retracted article. See vol. 48, pg. 743, 2019)
    Dixon, Anthony J.
    Steinman, Howard K.
    Nirenberg, Alexander
    Dixon, Zoe L.
    Anderson, Stuart
    Dixon, John B.
    AUSTRALIAN JOURNAL OF GENERAL PRACTICE, 2019, 48 (06) : 368 - 372
  • [5] RETRACTED: The myth of plant transformation (Retracted article. See vol. 37, pg. 827, 2019)
    Rao, Abdul Qayyum
    Bakhsh, Allah
    Kiani, Sarfraz
    Shahzad, Kamran
    Shahid, Ahmad Ali
    Husnain, Tayyab
    Riazuddin, S.
    BIOTECHNOLOGY ADVANCES, 2009, 27 (06) : 753 - 763
  • [6] RETRACTED: Menatetrenone for the treatment of osteoporosis (Retracted article. See vol. 20, pg. 1531, 2019)
    Iwamoto, Jun
    Sato, Yoshihiro
    EXPERT OPINION ON PHARMACOTHERAPY, 2013, 14 (04) : 449 - 458
  • [7] RETRACTED: Population Pharmacokinetic and Pharmacodynamic Analysis of Bosutinib (Retracted article. See vol. 34, pg. 163, 2019)
    Hsyu, Poe-Hirr
    Mould, Diane R.
    Abbas, Richat
    Amantea, Michael
    DRUG METABOLISM AND PHARMACOKINETICS, 2014, 29 (06) : 441 - 448
  • [8] RETRACTED: The Role of ERp44 in Maturation of Serotonin Transporter Protein (Retracted article. See vol. 294, pg. 70, 2019)
    Freyaldenhoven, Samuel
    Li, Yicong
    Kocabas, Arif M.
    Ziu, Enrit
    Ucer, Serra
    Ramanagoudr-Bhojappa, Raman
    Miller, Grover P.
    Kilic, Fusun
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2012, 287 (21) : 17801 - 17811
  • [9] RETRACTED: Introduction (Retracted article. See vol. 58, pg. 254, 2020)
    Goubier, Frederic
    Roques, Magali
    VIVARIUM-AN INTERNATIONAL JOURNAL FOR THE PHILOSOPHY AND INTELLECTUAL LIFE OF THE MIDDLE AGES AND RENAISSANCE, 2017, 55 (1-3): : 1 - 8
  • [10] RETRACTED: Candidate gene prioritization (Retracted article. See vol. 290, pg. 2357, 2015)
    Masoudi-Nejad, Ali
    Meshkin, Alireza
    Haji-Eghrari, Behzad
    Bidkhori, Gholamreza
    MOLECULAR GENETICS AND GENOMICS, 2012, 287 (09) : 679 - 698